NCT00162292View on ClinicalTrials.gov

Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate Background

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Rheumatoid Arthritis
Interventions
DRUG

BMS-582949 and Methotrexate

Trial Locations (10)

33484

Delray Research Associates, Delray Beach

34474

Ocala Rheumatology Research Center, Ocala

37520

Local Institution, León

52140

Local Institution, Metepec

75247

Covance Clinical Research Unit Inc., Dallas

78217

Radiant Research San Antonio Northeast, San Antonio

78229

Healthcare Discoveries, Inc, San Antonio

91786

Boling Clinical Trials, Upland

92260

Desert Medical Advances, Palm Desert

02720

Phase Iii Clinical Research, Fall River

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY